Lisinopril and metformin
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Lisinopril and Metformin: Pharmacokinetics, Interactions, and Clinical Implications
Pharmacokinetics of Lisinopril and Metformin
Simultaneous Determination in Pharmacokinetic Studies
A high-performance liquid chromatographic method has been developed and validated for the simultaneous determination of metformin and angiotensin-converting enzyme (ACE) inhibitors, including lisinopril, in bulk dosage forms. This method has been successfully applied to pharmacokinetic studies, demonstrating good linearity and reliability for both drugs.
Effect of Oral Semaglutide on Pharmacokinetics
Research has shown that oral semaglutide, a GLP-1 analog, does not significantly affect the pharmacokinetics of lisinopril. However, it does increase the area under the plasma concentration-time curve (AUC) of metformin by 32%, although this increase is not considered clinically relevant due to metformin's wide therapeutic index.
Drug Interactions Between Lisinopril and Metformin
In Vitro Interactions
In vitro studies have indicated that lisinopril can affect the dissolution profile of metformin. Specifically, the presence of lisinopril decreases the percentage of metformin released at various pH levels, while metformin increases the release of lisinopril at certain pH levels. These interactions are significant and suggest that co-administration of these drugs could alter their bioavailability.
Clinical Implications of Drug Interactions
A case study highlighted the potential for metformin-associated lactic acidosis in patients with normal renal and cardiac functions who are also taking lisinopril. This underscores the importance of monitoring patients for adverse effects when these drugs are co-administered.
Clinical Efficacy and Safety
Impact on Blood Glucose Levels
Lisinopril, when given alone or in combination with metformin, has been shown to have varying effects on blood glucose levels. In diabetic rats, lisinopril combined with metformin resulted in better glycemic control compared to lisinopril alone, suggesting a beneficial interaction in managing diabetes.
Combination Therapy in Hypertensive Diabetic Patients
A study on the combination of empagliflozin and metformin in patients with hypertension and type 2 diabetes mellitus (T2DM) found that adding empagliflozin to a regimen that includes metformin and lisinopril significantly improved glycemic control, blood pressure regulation, and promoted weight loss. This combination therapy was more effective than metformin and lisinopril alone.
Risks of Overdose
In cases of overdose, such as the ingestion of large quantities of metformin and lisinopril, patients can develop severe lactic acidosis and acute renal failure. Despite aggressive treatment, including continuous veno-venous hemofiltration (CVVH), outcomes can be fatal, highlighting the need for careful dosage management and monitoring.
Conclusion
The pharmacokinetics and interactions between lisinopril and metformin are complex and can significantly impact their clinical efficacy and safety. While combination therapies involving these drugs can offer enhanced benefits for managing conditions like hypertension and T2DM, they also pose risks that require careful monitoring. Further research and clinical vigilance are essential to optimize therapeutic outcomes and minimize adverse effects.
Sources and full results
Most relevant research papers on this topic